Charles River Laboratories International, Inc. (CRL)

203.83 +0.17 (+0.08%) USD  |  NYSE  |  Dec 29, 09:54
More

Charles River Laboratories International Amortization Expense CF (% of Quarterly Assets)

Amortization Expense CF (% of Quarterly Assets) Chart

View Amortization Expense CF (% of Quarterly Assets) for CRL.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Amortization Expense CF (% of Quarterly Assets) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years

View Amortization Expense CF (% of Quarterly Assets) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Amortization Expense CF (% of Quarterly Assets) Benchmarks

View Amortization Expense CF (% of Quarterly Assets) Benchmarks
Start Trial
Johnson & Johnson Upgrade
Eli Lilly & Co. --
Thermo Fisher Scientific, Inc. Upgrade
IQVIA Holdings, Inc. --
Medpace Holdings, Inc. Upgrade